Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREPARE STUDY: PRevalence of the Eosinophilic Phenotype Among SeveRE Asthma Patients in AstraZeneca International Region. A Multinational, Cross-Sectional, Multicenter Study

NCT03931954 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03931954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03931954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREPARE STUDY: PRevalence of the Eosinophilic Phenotype Among SeveRE Asthma Patients in AstraZeneca International Region. A Multinational, Cross-Sectional, Multicenter Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 15, 2019
Completion date
November 26, 2020
Enrollment
794 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma